Sassicaia Capital Advisers’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Sassicaia Capital Advisers’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-27,000	Closed	-$31K	–	19
2022 Q2	$31K	Buy	+27,000	New	+$44.5K	0.19%	14

Other funds holding EVFM

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Sassicaia Capital Advisers's EVFM Position: Q3 2022 in Review

Sassicaia Capital Advisers sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 27,000 shares — an estimated $31K sold.

Sassicaia Capital Advisers first reported a position in EVFM in Q2 2022 and held it in 1 quarter. The position peaked at $31K in Q2 2022. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

Sassicaia Capital Advisers reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Sassicaia Capital Advisers sold 27,000 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $31K.
Sassicaia Capital Advisers first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Sassicaia Capital Advisers's Evofem Biosciences, Inc. Common Stock position peaked at $31K in Q2 2022.
8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Sassicaia Capital Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.